(Q38537928)

3 September 2017

0 references

1 reference

title

Meta-analysis of Liver Resection Versus Nonsurgical Treatments for Pancreatic Neuroendocrine Tumors with Liver Metastases (English)

1 reference

3 September 2017

1 reference

Chun-Hui Yuan

1

1 reference

3 September 2017

Jing Wang

2

1 reference

3 September 2017

Dian-Rong Xiu

3

1 reference

3 September 2017

Ming Tao

4

1 reference

3 September 2017

Zhao-Lai Ma

5

1 reference

3 September 2017

Bin Jiang

6

1 reference

3 September 2017

Zhi-Fei Li

7

1 reference

3 September 2017

Lei Li

8

1 reference

3 September 2017

Liang Wang

9

1 reference

3 September 2017

Hangyan Wang

10

1 reference

3 September 2017

Tong-Lin Zhang

11

1 reference

3 September 2017

26 June 2015

1 reference

Annals of Surgical Oncology

3 September 2017

1 reference

3 September 2017

23

1 reference

3 September 2017

1

1 reference

3 September 2017

244-249

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-015-4654-5

3 September 2017

0 references

cites work

Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4654-5

Population-based study of islet cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4654-5

Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4654-5

Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4654-5

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4654-5

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4654-5

Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4654-5

Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4654-5

Hepatic neuroendocrine metastases: does intervention alter outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4654-5

Surgery in malignant pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4654-5

Should hepatic resections be performed at high-volume referral centers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4654-5

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4654-5

10.1245/S10434-015-4654-5

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference